EHElbert S. Huang

Elbert S. Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elbert S. Huang has a total of 287 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low‐Intensity Social Care for Dementia Caregivers: A Randomized Trial

    by Jennifer A. Makelarski, Kristen E. Wroblewski, Victoria A. Winslow, Emily M. Abramsohn, Soo Borson, Delaney A. Romanchick, Dena Schulman‐Green, Katherine Thompson, Elbert S. Huang, Stacy Tessler Lindau

    Background: Resource needs increase strain among dementia caregivers. We tested the impact of CommunityRx‐Dementia, a low‐intensity resource referral intervention that provides education about common resource needs, a personalized list of nearby resources, and navigation support via a navigator and online resource finder. Methods: We conducted a single‐blind RCT comparing usual care (control) versus usual care plus CommunityRx‐Dementia (intervention). We enrolled (12/2020–2/2024) English‐speaking dementia caregivers agreeing to receive text messages who lived in a 62 ZIP code geography around an urban academic medical center. We assessed caregiver self‐efficacy (primary, 12 months), loneliness, need for help and self‐reported hospitalizations and emergency department (ED) visits (other pre‐specified outcomes). Pre‐planned, main analyses included participants with ≥ 1 baseline health‐related social risk (HRSRs); post hoc analyses included caregivers without baseline HRSRs. Results: Caregivers with HRSRs ( n = 133) were predominantly female (84%) and Black (79%); 52% had household income < $50 K/year; 94% texted a navigator and 31% requested additional resource information. Caregiver self‐efficacy (range 1–5, intervention = 3.5; control = 3.5, odds ratio [OR]: 0.80, 95% CI: 0.30, 2.09) and rates of loneliness (intervention = 41%; control = 50%; OR: 0.62, 95% CI: 0.24, 1.59), needing help (23% = intervention, 34% = control; OR: 0.80, 95% CI: 0.30, 2.11) and hospitalization (intervention = 0.1, control = 0.2; IRR: 0.42, 95% CI: 0.14, 1.30) were similar at 12 months, but ED utilization was lower in the intervention group (0.3 vs. 0.7, IRR: 0.41, 95% CI: 0.19, 0.90). Caregivers without HRSRs ( n = 210) were mainly female (75%) and Black (82%); 25% had household income < $50 K/year; 95% texted a navigator and 39% requested additional resource information. Self‐efficacy, loneliness, hospitalizations, and ED utilization were similar between arms at 12 months, but odds of needing help were 0.31 (95% CI: 0.12, 0.83) for the intervention group. Conclusions: A low‐intensity social care intervention aimed at dementia caregivers did not improve self‐efficacy at 12 months but reduced emergency care utilization among those with HRSRs. Trial Registration: ClinicalTrials.gov , Registered 10/29/19, Identifier: NCT04146545

  • Open Access

    Caregivers in a Haystack? Informatics‐Driven Clinical Trial Enrollment of Dementia Caregivers at Medical Visits

    by Eva S. Ren, Jennifer A. Makelarski, Delaney A. Romanchick, Veera Anand, Victoria A. Winslow, Emily M. Abramsohn, MariaDelSol De Ornelas, Elbert S. Huang, Katherine Thompson, Soo Borson, et al.

    Background: Caregiving status is not routinely documented during clinical care, rendering caregivers difficult to identify for research and supportive interventions. We describe two informatics‐based strategies for identifying dementia caregivers at their own or their care recipient's point of care (POC). Methods: The CommunityRx‐Dementia trial was conducted at a U.S. urban academic medical center serving a predominantly Black population. Eligible participants were caregivers of a patient with dementia recruited mainly by: (1) fee‐based queries of the clinical research data warehouse (CRDW) that identified patients with dementia and their listed contacts (potential caregivers) (August 2020–November 2022) or (2) no‐cost self‐service query using an electronic health record (EHR)‐integrated cohort discovery tool that identified patients with dementia (June 2020). For CRDW lists, probabilistic matching was used to identify contacts who were also patients at the study site. An EHR dashboard displayed medical visits of patients with dementia (identified from both strategies) and their contacts (from CRDW only) to recruit at the POC. Results: A recruitment list of 8185 patients with dementia was created: 6282 from five CRDW queries and 1883 from one self‐service EHR query, 20 from self‐ and clinician referrals. Target enrollment ( N = 344) was reached in 27 months; 321 caregivers from CRDW contacts, 19 from self‐service query contacts, 4 from clinician referrals. Enrollment rates were 66% (321/488) of eligible caregivers from CRDW and 48% (19/40) from self‐service query. Seventeen percent of all enrolled caregivers were recruited from their own visit (28% internal medicine, 11% ophthalmology, 9% geriatrics, 5% hematology/oncology, 47% all other eligible clinics). Conclusions: A large dementia caregiver trial achieved recruitment goals using two replicable informatics‐based strategies. The CRDW strategy involved no manual EHR abstraction and enabled direct recruitment of dementia caregivers at their own medical visits at relatively low cost.


  • Letter to the American Diabetes Association Board of Directors From Members of the Mentor Advisory Committee, ADA Pathway to Stop Diabetes Program

    by Barbara Anderson, Mark Anderson, David D’ALessio, Mary de Groot, Robert Eckel, David Harlan, Kevan Herold, Elbert Huang, Rohit Kulkarni, Lori Laffel, et al.

  • Sneakers 2 Scrubs: An Innovative Approach to Addressing Underrepresentation of Black Males in Medical School Pipeline Programs

    by Marcus Allen, Jameel Alausa, Ahmed Abdel Naby, Johari Shuck, Abdullah Pratt, Elbert S. Huang, Nathaniel J Glasser

  • Open Access

    Effectiveness of Interventions to Improve Glycemic Control in US Asian and Pacific Islander Populations With Type 2 Diabetes: Systematic Review and Meta-Analysis

    by Jason Xiao, Jielu Yu, Erin M Staab, Nikita C Thomas, Wen Wan, Amber N Deckard, Andrew J Karter, Monica E Peek, Elbert S Huang, Neda Laiteerapong

    Background: Asian American and Pacific Islander populations are disproportionately affected by diabetes. Objective: The purpose of this study was to assess the efficacy of nonpharmacologic interventions in reducing hemoglobin A 1c (HbA 1c ) levels among Asian American or Pacific Islander individuals with type 2 diabetes. Methods: A systematic review was conducted using the PubMed, Scopus, PsycInfo, and CINAHL databases, covering studies published from 1985 to 2019. Eligible studies were randomized controlled trials that evaluated nonpharmacologic interventions in outpatient settings for adults with type 2 diabetes in the United States, with at least 50% Asian American or Pacific Islander participants. Data extraction and risk of bias assessment were independently performed by 2 reviewers for each trial. The Cochrane Collaboration risk of bias tool and the Grading of Recommendations, Assessment, Development, and Evaluation approach were used to evaluate quality. Random-effects meta-analyses were conducted to estimate pooled effect sizes. Results: A total of 1835 articles were screened, with 9 randomized controlled trials meeting the inclusion criteria, comprising 1492 participants, with a median follow-up duration of 6 (IQR 3-12) months. Interventions included diabetes self-management education, bilingual counseling, glucose or weight monitoring, motivational interviewing, and financial support, often tailored to the cultural context of the participants. Pooled analysis of the 9 trials demonstrated a significant average HbA 1c reduction of −0.39% (95% CI −0.64% to −0.14%; I ²=65%). Seven studies were judged to have a low risk of bias, 1 study had some concerns, and 1 study was assessed as high risk. The overall strength of evidence was high. Conclusions: Nonpharmacologic interventions substantively reduced HbA 1c levels in Asian American or Pacific Islander individuals with type 2 diabetes, particularly when culturally and linguistically tailored.

  • Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood

    by Anna R. Kahkoska, Joshua J. Neumiller, Anastasia-Stefania Alexopoulos, Amlan Barik, Elbert S. Huang, Lori M. Laffel, Naushira Pandya, Christine Slyne, Elena Toschi, Ruth S. Weinstock, et al.

    As care for type 1 diabetes (T1D) advances, the number of adults with T1D living into older adulthood (ages ≥65 years) continues to grow. The population of older adults with T1D is highly heterogeneous, and over the life span, various factors may change over time while others may not, necessitating an individualized approach to management. A key care consideration for people with T1D is the ongoing need for exogenous insulin replacement intensive self-monitoring for effective management. At the same time, growing older may bring changes such as increased risk of misdiagnosis of T1D as type 2 diabetes, greater vulnerability to hypoglycemia, accumulating comorbidities and complications, declining independence due to geriatric syndromes, and a growing need for support in using diabetes technologies and navigating complex care transitions. Given the unique clinical and management needs of this population, we sought to present key care challenges in this population and suggest strategies to optimize quality of care in older adults with T1D, including 1) integrating geriatric screenings, age-friendly care frameworks, and regular reassessments into routine T1D management; 2) developing tailored care approaches for cognitive impairment; 3) establishing support systems for diabetes technology use in primary and long-term care settings; and 4) ensuring insurance coverage and access to diabetes technologies and therapies. Forward-thinking strategies to optimize care include individualized glycemic goal setting, the development and adoption of care models that support continuity of diabetes technology use, and individualized management strategies that consider of the goals and capabilities of the person living with T1D and care partners.


  • Collaborators in Health: Redefining Research–Community Partnerships, Chicago, 2022–2024

    by Elizabeth B. Lynch, Santosh Basapur, Doriane C. Miller, Lisa A. Kuklinski, Sheila A. Dugan, Christie Edwards, Morris Reed, Dee Atkins, Cecile DeMello, Carlos Nelson, et al.

    Effective community-engaged research is critical for designing and testing solutions to decrease the 10-year life expectancy gap between Black and non-Black residents of Chicago, Illinois. In community listening sessions, the Chicago Chronic Conditions Engagement Network found that community members’ highest priority health issues were social determinants of health and that there is a strong mistrust of research. Conversations with leaders of community organizations addressing social determinants of health suggest strategies to help researchers overcome mistrust and build effective community–research partnerships. ( Am J Public Health. 2025;115(S2):S130–S133. https://doi.org/10.2105/AJPH.2025.308082 )

  • Common Data Element (CDE) Success from Community-Engagement Not Mandates: If You Build It [Data Warehouse], Will They [Participants] Come?

    by Stuart A. Gansky, Alex C. Cheng, Dinesh Mendhe, Aryanna Chavez, Hsin-Chieh Yeh, Kathy Lanier, William Brown, Derek E. Hersch, Elbert S. Huang, Felicity T. Enders, et al.


  • Deprescribing in Older Adults With Type 2 Diabetes: Associations With Patients' Perspectives: The Diabetes and Aging Study

    by Melissa M. Parker, Kasia J. Lipska, Lisa K. Gilliam, Richard W. Grant, Shanzay Haider, Elbert S. Huang, Rajesh K. Jain, Neda Laiteerapong, Jennifer Y. Liu, Howard H. Moffet, et al.

    Background: Little is known about how patients' preferences, expectations, and beliefs (jointly referred to as perspectives) influence deprescribing. We evaluated the association of patients' self‐reported perspectives with subsequent deprescribing of diabetes medications in older adults with type 2 diabetes. Methods: Longitudinal cohort study of 1629 pharmacologically treated adults ages 65–100 years with type 2 diabetes who received care at Kaiser Permanente of Northern California (KPNC) and participated in the Diabetes Preferences and Self‐Care survey (2019). The survey asked questions about perspectives regarding the use of diabetes medications. Deprescribing was identified during the 24 months following the survey and defined as any of the following: discontinuation of one or more therapeutic classes, reduction in frequency of daily dosing, reduction in total daily pill count, or reduction in total daily dose for oral hypoglycemic agents. Rates of deprescribing and measures of relative risk were calculated for patients' perspectives and select clinical factors. Models predicting deprescribing were adjusted for age, sex, race/ethnicity, health literacy, baseline number of diabetes medications, duration of diabetes, overtreatment per Endocrine Society guidelines, and KPNC eligibility for targeted deprescribing and weighted to account for the age‐stratified complex sampling design and survey response. Results: Six hundred seventy‐three (38%) patients experienced deprescribing over a mean follow‐up of 23 months. Deprescribing was significantly associated with the following patient perspectives: not expecting to need diabetes medication for life (RR = 1.48, 95% CI: 1.07–2.03) and not recognizing that taking fewer medications could lead to higher blood sugar levels (RR = 1.31, 95% CI: 1.09–1.58). Conclusions: Patients' perspectives may enable or hinder deprescribing, emphasizing the importance of soliciting these perspectives during shared decision‐making. Effective deprescribing will benefit from understanding patients' perspectives and fostering patient–provider communication about medication changes throughout the disease course.


  • Open Access

    Effectiveness of Multilevel and Multidomain Interventions to Improve Glycemic Control in U.S. Racial and Ethnic Minority Populations: A Systematic Review and Meta-analysis

    by Eli M. Falk, Erin M. Staab, Amber N. Deckard, Sofia I. Uranga, Nikita C. Thomas, Wen Wan, Andrew J. Karter, Elbert S. Huang, Monica E. Peek, Neda Laiteerapong

    BACKGROUND: Racial and ethnic disparities in type 2 diabetes outcomes are a major public health concern. Interventions targeting multiple barriers may help address disparities. PURPOSE: To conduct a systematic review and meta-analysis of diabetes self-management education (DSME) interventions in minority populations. We hypothesized that interventions addressing multiple levels (individual, interpersonal, community, and societal) and/or domains (biological, behavioral, physical/built environment, sociocultural environment, and health care system) would have the greatest effect on hyperglycemia. DATA SOURCES: We performed an electronic search of research databases PubMed, Scopus, CINAHL, and PsycINFO (1985–2019). STUDY SELECTION: We included randomized controlled trials of DSME interventions among U.S. adults with type 2 diabetes from racial and ethnic minority populations. DATA EXTRACTION: We extracted study parameters on DSME interventions and changes in percent hemoglobin A1c (HbA1c). DATA SYNTHESIS: A total of 106 randomized controlled trials were included. Twenty-five percent (n = 27) of interventions were exclusively individual-behavioral, 51% (n = 54) were multilevel, 66% (n = 70) were multidomain, and 42% (n = 45) were both multilevel and multidomain. Individual-behavioral interventions reduced HbA1c by −0.34 percentage points (95% CI −0.46, −0.22; I2 = 33%) (−3.7 [−5.0, −2.4] mmol/mol). Multilevel interventions reduced HbA1c by −0.40 percentage points (95% CI −0.51, −0.29; I2 = 68%) (−4.4 [−5.6, −3.2] mmol/mol). Multidomain interventions reduced HbA1c by −0.39 percentage points (95% CI −0.49, −0.29; I2 = 68%) (−4.3 [−5.4, −3.2] mmol/mol). Interventions that were both multilevel and multidomain reduced HbA1c by −0.43 percentage points (95% CI −0.55, −0.31; I2 = 69%) (−4.7 [−6.0, −3.4] mmol/mol). LIMITATIONS: The analyses were restricted to RCTs. CONCLUSIONS: Multilevel and multidomain DSME interventions had a modest impact on HbA1c. Few DSME trials have targeted the community and society levels or physical environment domain. Future research is needed to evaluate the effects of these interventions on outcomes beyond HbA1c.